The clinical research program at the Metropolitan Heart and Vascular Institute participates in the advancement of science and medicine through our involvement in research studies. We partner closely with academic centers and industry leaders to answer important questions about treatment and to bring the latest in cutting edge cardiovascular therapy and prevention to our patients. Over the last decade, our cardiovascular experts have participated in more than 70 clinical research studies in the areas of interventional cardiology, heart rhythm, and vascular disease.
Current Research Studies
CHAMPION-AF. This study is a prospective, clinical trial which randomizes patients to either the WATCHMAN FLX Left Atrial Appendage Closure Device (“Device Group”) or a commercially available non-vitamin K oral anticoagulant (DOAC).
Extravascular ICD Pivotal Study. The study is designed to demonstrate safety and efficacy of the Extravascular Implantable Cardioverter Defibrillator (EV ICD) System.
Coronary Artery Disease
ONYX Post-Approval Study. The purpose of this study is to evaluate the safety and effectiveness of the Medtronic Resolute Onyx™ Stent System.
ECLIPSE. This study evaluates the treatment strategies for severe calcified coronary arteries by comparing the use of orbital atherectomy versus conventional balloon angioplasty prior to stent placement.
Peripheral Artery Disease
RANGER. This research study compares standard balloon treatment versus drug coated balloon for patients with peripheral vascular disease in their legs.